To evaluate its role in the treatment of glioma, downregulation of HSP90AA1-IT1 (HSP90AA1 intronic transcript (1) was done, which could significantly suppress cell viability, proliferation, EMT, invasion, and migration of glioma [92]. The gene discussed is HSP90AA1; the disease is central nervous system cancer.